What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?

Leiomyosarcoma is one of the most common subtypes of soft tissue sarcomas accounting for approximately 20% of sarcomas. As leiomyosarcoma patients frequently develop metastatic disease, effective systemic therapies are needed to improve clinical outcomes. The overall activity of the currently availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, Bernd, D’Ambrosio, Lorenzo, Davis, Elizabeth J., Ingham, Matthew, Broto, Javier Martin, Trent, Jonathan C., van Houdt, Winan J., Van Tine, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Sarcoma (SH Okuno, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930904/
https://www.ncbi.nlm.nih.gov/pubmed/35275323
http://dx.doi.org/10.1007/s11864-021-00928-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930904/
https://www.ncbi.nlm.nih.gov/pubmed/35275323
http://dx.doi.org/10.1007/s11864-021-00928-y

Ejemplares similares